合景泰富集团(01813)发布公告，2025年11月，本集团及其合营企业及联营公司的预售额为人民币5.11亿 元，与去年同期相比减少21.4%。本集团及其合营企业及联营公司的预售建筑面积约为2.87万平方米， 与去年同期相比减少12.8%。 ...

智通财经APP讯，合景泰富集团(01813)发布公告，2025年11月，本集团及其合营企业及联营公司的预售 额为人民币5.11亿元，与去年同期相比减少21.4%。本集团及其合营企业及联营公司的预售建筑面积约 为2.87万平方米，与去年同期相比减少12.8%。 ...

格隆汇12月15日丨合景泰富集团(01813.HK)发布公告，2025年11月，集团及其合营企业及联营公司的预 售额为人民币5.11亿元，与去年同期相比减少21.4%。集团及其合营企业及联营公司的预售建筑面积约 为2.87万平方米，与去年同期相比减少12.8%。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 KWG GROUP HOLDINGS LIMITED 合景泰富集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1813） 2025年11月之 未經審核營運數據 合景泰富集團控股有限公司（「本公司」）董事會（「董事會」或「董事」）欣然公佈本公司 及其附屬公司（「本集團」）連同其合營企業及聯營公司2025年11月之若干未經審核營 運數據如下。 2025年11月，本集團及其合營企業及聯營公司之預售額為人民幣5.11億元，與去年 同期相比減少21.4%。本集團及其合營企業及聯營公司之預售建築面積約為28,700 平方米，與去年同期相比減少12.8%。 上述銷售數據未經審核，乃根據本集團及其合營企業及聯營公司初步內部資料編 製，鑒於收集該等銷售資料過程中存在各種不確定因素，該等銷售數據與本公司按 年度或半年度刊發的經審核或未經審核綜合財務報表中披露的數字可能存在差異， 因此上述數據僅供投資者參考。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 KWG GROUP HOLDINGS LIMITED 合景泰富集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1813） 重續持續關連交易 上市規則涵義 於本公告日期，孔健岷先生、孔健濤先生及孔健楠先生根據彼等各自受控實體之 間訂立的有關股東協議，各自為本公司及合景悠活的最終控股股東。因此，合景 悠活（作為本公司控股股東的聯繫人）為本公司關連人士。各新框架協議項下擬進 行的交易構成本公司的持續關連交易。 – 1 – (A) 部分豁免協議 由於有關各部分豁免協議最高建議年度上限的最高適用百分比率（利潤率除 外）（定義見上市規則）超過0.1%但全部低於5%，因此，各部分豁免協議及其 項下擬進行的交易將分別須遵守上市規則第14A章項下報告、年度審閱及公 告的規定，惟獲豁免遵守通函（包括獨立財務意見）及獨立股東批准的規定。 (B) 非豁免協議 由於有關各非豁免協議最高建議年度上限的最高適用百分比 ...

Market Overview - The Hong Kong stock market experienced a volatile trading day on December 9, with the Hang Seng Index closing down 1.29% at 25,434.23 points, the Hang Seng Tech Index down 1.90% at 5,554.68 points, and the National Enterprises Index down 1.62% at 8,936.41 points [1] - Technology stocks generally declined, with notable drops in Bilibili, Xiaomi, and Baidu, each falling over 3%, while Kuaishou and Meituan dropped over 2% [1] - Gold and non-ferrous metal stocks faced pressure, with Zijin Mining down over 4% [1] - Real estate stocks weakened significantly, with Yaloo Group plunging over 18% [1] - The semiconductor sector saw substantial declines, with Huahong Semiconductor down over 5% and SMIC down over 4% [1] - New consumption concept stocks also fell, with Pop Mart down over 5% [1] - Pharmaceutical stocks performed well, with Genscript Biotech rising 18%, Hongteng Precision up 11%, and Zhaoyan New Drug up 5.9% [1] Company News - Dongfeng Group reported cumulative sales of 1.697 million vehicles in the first 11 months, a slight decrease of approximately 0.3% year-on-year, while new energy vehicle sales reached 489,203 units, marking a 39.1% increase [2] - New天绿色能源 achieved a cumulative power generation of 13.3689 million MWh in the first 11 months, an increase of 8.04% year-on-year, with November's generation at 1.662 million MWh, up 24.45% [2] - Longyuan Power completed a cumulative power generation of approximately 69.0964 million MWh in the first 11 months, reflecting a year-on-year growth of 0.41% [2] - Greenland Hong Kong reported contract sales of approximately 6.823 billion yuan in the first 11 months, a decline of 22.6% year-on-year [3] - Sunny Optical Technology completed a share swap merger with GoerTek, with its subsidiary Ningbo Aolai holding approximately 31.31% of the shares, becoming the second-largest shareholder [3] - Zoomlion Heavy Industry completed the acquisition of 81% of the shares in Zoomlion Heavy Industry Finance Leasing (Beijing) [4] - Cambridge Technology plans to increase its investment in CIG USA by $100 million [5] - WuXi AppTec announced research data for JWCAR201 IIT at the 67th American Society of Hematology Annual Meeting [6] - Four Seasons Pharmaceutical's innovative drug Anjiuwei® was successfully renewed for inclusion in the 2025 National Basic Medical Insurance Drug List, while its innovative drug Xuanyue Ning® was included for the first time [6] - Yuan Da Pharmaceutical's Class 1 innovative drug GPN01360 successfully reached clinical endpoints in a Phase II clinical study conducted in China [7] - Agile Group's hearing has been further postponed to March 9, 2026 [8] Institutional Insights - Bank of China International views the recent market adjustment as a normal phenomenon in a bull market, maintaining a positive outlook for the Hong Kong stock market, predicting the Hang Seng Index could reach 30,100 points by December 2026 [9] - Huaxia Fund believes that the previous irrational panic in the tech sector has eased, and with AI development paths becoming clearer, it is advisable to position for a recovery in the market [9] - Everbright Securities notes that the Hang Seng Index's current P/E ratio is above its five-year average, indicating a reasonable valuation range, while the tech index has room for growth [9] - Guosen Securities suggests that the recent market adjustment opens up space for future growth, with significant net inflows from southbound funds into the Hong Kong market [10]

Market Overview - The US stock market experienced a collective decline, leading to a weak market sentiment in Hong Kong, with the Hang Seng Index down 0.84% to 25,549.90 points, the Hang Seng Tech Index down 1.32% to 5,587.69 points, and the National Enterprises Index down 1.12% to 8,981.84 points [1] Company News - Dongfeng Group reported cumulative sales of 1.697 million vehicles in the first 11 months, a year-on-year decrease of approximately 0.3%. New energy vehicle sales reached 489,203 units, marking a year-on-year increase of about 39.1% [2] - New天绿色能源 achieved a cumulative power generation of 13.3689 million MWh in the first 11 months, an increase of 8.04% year-on-year, with November's generation at 1.662 million MWh, up 24.45% year-on-year [2] - Longyuan Power completed a cumulative power generation of approximately 69.0964 million MWh in the first 11 months, reflecting a year-on-year growth of 0.41% [3] - Greenland Hong Kong reported contract sales of approximately 6.823 billion yuan in the first 11 months, a year-on-year decline of 22.6% [4] - Sunyu Optical Technology completed a share swap merger with Goer Optical, with its subsidiary Ningbo Aolai holding approximately 31.31% of the shares, becoming the second-largest shareholder [4] - Zoomlion Heavy Industry completed the acquisition of 81% equity in Zoomlion Heavy Industry Finance Leasing (Beijing) [5] - Cambridge Technology plans to increase its investment in CIG USA by $100 million [6] - WuXi AppTec announced research data for JWCAR201 IIT at the 67th American Society of Hematology Annual Meeting [7] - Four Seasons Pharmaceutical's innovative drug Anjiuwei® successfully renewed its inclusion in the 2025 National Basic Medical Insurance Drug List, while its innovative drug XuanYueNing® was included for the first time [7] - Yuanda Pharmaceutical's Class 1 innovative drug GPN01360 successfully reached clinical endpoints in Phase II clinical trials in China [8] - Agile Group's hearing has been further postponed to March 9, 2026 [9] Institutional Insights - Haitong International suggests that after market consolidation, a rebound is expected, with technology stocks having room for recovery. The rebound's strength will depend on policy implementation and potential interest rate cuts by the Federal Reserve [10] - Everbright Securities notes that the Hang Seng Index's current P/E ratio is above its 5-year average, indicating overall valuation recovery, while the tech index has just returned to its 5-year average, suggesting room for further valuation catch-up [10] - Guosen Securities predicts that the short-term adjustment in Hong Kong stocks opens up space for market growth in 2026, with net inflows from southbound funds exceeding 110 billion yuan in November [10]

智通财经APP讯，合景泰富集团(01813)发布公告，于2025年12月8日，高等法院已将该呈请的聆讯进一 步延期至2026年3月9日。 ...

格隆汇12月8日丨合景泰富集团(01813.HK)公告，于2025年12月8日，高等法院已将该呈请的聆讯进一步 延期至2026年3月9日。公司将就有关呈请的任何重大发展知会其股东及投资者，并适时另行刊发公告。 ...

合景泰富集团(01813)发布公告，于2025年12月8日，高等法院已将该呈请的聆讯进一步延期至2026年3 月9日。 ...